Legislators
Bills
Statements
Represent

H.R.3709: Protecting Consumer Access to Generic Drugs Act of 2013

About this Bill

This bill was introduced in the 113th Congress
This bill is primarily about commerce
You can read the bill
Sponsor Bobby L. Rush, D-Ill.
Total Cosponsors 5 (All Democrats)
Introduced Dec. 11, 2013
Latest Major Action Jan. 27, 2014
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the House   
  • Bill passed in the House   
  • Bill passed in the Senate   
  • Bill signed into law

Bill Summary

Protecting Consumer Access to Generic Drugs Act of 2013 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market or sell the generic drug. Excludes a resolution or settlement that includes no more than: (1) the right to market the generic drug before the expiration of the patent or other exclusivity period, or (2) the waiver of a patent infringement claim for damages.

Authorizes the Federal Trade Commission (FTC) to exempt agreements in furtherance of market competition and for the benefit of consumers.

Amends the Federal Food, Drug, and Cosmetic Act to deem an applicant to have forfeited market exclusivity if the applicant enters into ...

(Source: Congressional Research Service)

Bill Actions

Date Description
Jan. 27, 2014 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Jan. 27, 2014 Referred to the Subcommittee on Regulatory Reform, Commercial And Antitrust Law.
Dec. 13, 2013 Referred to the Subcommittee on Health.
Dec. 11, 2013 Referred to House Judiciary
Dec. 11, 2013 Referred to House Energy and Commerce